Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

Clinical trial NCT06516406 · RECRUITING

Trial details

NCT number: NCT06516406
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: RECRUITING
Study type: OBSERVATIONAL

Myelofibrosis Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2022-05-06
Primary completion: 2032-05-31
Enrollment: 1055

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.